Company Filing History:
Years Active: 2014
Title: Patrick Paulus - Innovator in Pharmaceutical Chemistry
Introduction
Patrick Paulus is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address critical health issues. His work focuses on innovative solutions for treating hyper-proliferative disorders and diseases associated with angiogenesis.
Latest Patents
Patrick Paulus holds a patent for "Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis." This invention relates to novel heteroaryl substituted pyrazole compounds, pharmaceutical compositions containing such compounds, and the use of those compounds or compositions for treating hyper-proliferative and/or angiogenesis disorders, either as a sole agent or in combination with other active ingredients or therapeutic measures. He has 1 patent to his name.
Career Highlights
Patrick is currently employed at Bayer Intellectual Property GmbH, where he continues to advance his research and development efforts. His work at Bayer has positioned him as a key player in the pharmaceutical industry, contributing to the development of innovative treatments.
Collaborations
Throughout his career, Patrick has collaborated with esteemed colleagues, including Stephen James Boyer and Michael Härter. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Patrick Paulus exemplifies the spirit of innovation in pharmaceutical chemistry. His contributions to the development of novel compounds for treating serious health conditions highlight the importance of research and collaboration in advancing medical science.